tells Citi, BofA to raise capital -WSJ Stocks | Mexico * WHO raises pandemic alert level * BA, tour operators fall; drugmakers gain By Dominic Lau LONDON, April 28 (Reuters) – Britain’s top share index lost2.3 percent by midday on Tuesday on intensifying concerns over aswine flu outbreak and on fears of banks needing more capital. Veeva is a privately-held company headquartered in Pleasanton, CA.For more information, visit Veeva Systems, Inc.Lisa Barbadora, Copyright Business Wire 2009. Veeva customers achieve the fastest timeto value through the deployment of fully functional applications that areflexible, simple to deploy, inexpensive to operate, and provide a superior userexperience. Veeva has dozens of customers ranging from the world`s largestpharmaceutical companies with thousands of users to emerging biotechscommercializing their first products. The complete Veeva CRM suite gives customers the mobility andreporting solutions needed to drive user adoption and sales effectiveness. It isalso the only Pharma CRM application to come pre-validated for PDMA and CFR Part11 compliance.
As thefoundation, VBioPharma offers multiple editions in one CRM product toaccommodate the unique needs of various life sciences commercial teams. Those improvements, if Torre can bring himself to make them, should more than offset any age-related decline from Jeff Kent and/or a return to earth by Russel Martin. He's totaled 137 innings the last two years, with ERAs of 2.96 and 3.88, and should continue to do well in that role in 2008 Rudy Seanez, now 39 years old, is also in the mix. Bullpen: Closer Takashi Saito has been nothing short of brilliant since he crossed the Pacific two winters ago: 63 saves in 69 chances, 185 strikeouts in 142 innings, and a Mariano-esque 1.77 ERA. In any case, the front four should be good enough that the No 5 man doesn't matter too much.
If not him, then Joe Torre has Yankee cast-off (and inexplicable favorite) Tanyon Sturtze on whom to fall back. If those two are any indication, Kuroda may be in for a rough season.Rounding out the top five is Esteban Loaiza, who's trying to get healthy and pitch a full season for the first time since 2005. The big differences have come in the Loss column, due to bad luck and/or poor run support. He's pitched between 199 and 222 innings, with 12 to 16 wins and an ERA between 3.61 and 3.88 each of those three years. Lowe, whose performance was wildly erratic his last few years in Boston, has been the very picture of consistency in the three years he's spent in LA. He's been in the top 3 in the NL in Outs made each of the last 5 years, leading it twice, with his only real competition coming form Jimmy Rollins, who at least hits for some power and plays better defense.Bench:Still, having Pierre on the bench to spot start, pinch-run, or try to slap a key single in the late innings can be helpful Just not worth the $55 million contract he signed.